Drug · DIN 02417863
DOCUSATE SODIUM
SOFTGEL
No: cancelled
Cancelled by Health Canada because the company did not file its annual notification.
Status Cancelled (Unreturned Annual) since January 8, 2024.
- Drug Identification Number (DIN)
- 02417863
- Company (DIN owner)
- NuGale Pharmaceutical Inc.Toronto, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Docusate sodium A06AA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DOCUSATE SODIUM | 100 MG |
Other DINs named DOCUSATE SODIUM
- DIN 02426838 · Marketed
- DIN 00870218 · Cancelled Post Market
- DIN 02246036 · Cancelled Post Market
- DIN 02246854 · Cancelled Post Market
- DIN 02289873 · Dormant
- DIN 02326086 · Cancelled Post Market
- DIN 02437325 · Cancelled Pre Market
- DIN 02464608 · Cancelled Pre Market
- DIN 02492644 · Approved
- DIN 02500922 · Approved